Figure 5
From: Metallopanstimulin as a marker for head and neck cancer
Patient followed for 24 months without evidence of recurrence on physical exam, endoscopy, or FDG-PET.
Figure 5 | World Journal of Surgical Oncology
From: Metallopanstimulin as a marker for head and neck cancer
Patient followed for 24 months without evidence of recurrence on physical exam, endoscopy, or FDG-PET.